![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
PUBLIC RELEASE DATE: 30-Oct-2013
[
]
ShareContact: Nick Seaver
nseaver@burnesscommunications.com
301-280-5727
Burness Communications
Engaging new partners to save lives
The Global Health Innovative Technology Fund (GHIT Fund), along with the New York Academy of Sciences and Japan Society, will host a panel discussion comprised of preeminent global health experts to examine recent successes and setbacks in global health and what they see as the secret ingredient to moving a vaccine, cure or diagnostic across the finish line and into the field.
Panelists will provide their unique perspectives on:
- How do these partnerships find success in the face of seemingly insurmountable challenges?
- What have we learned from past successes that make the difference between a breakthrough diagnostic or treatment and a trip back to the drawing board?
- Where are the opportunities for the next big solutions?
- Who is missing from the table in the effort to push back against HIV, TB, malaria and neglected tropical diseases?
- Why should those outside the global health and NGO worlds join this effort?
The discussion will include an opportunity for questions from attendees. A networking reception will follow the panel.
When: 6-8:30pm
November 12, 2013
Who:
Panelists:
- Peter Piot, M.D., Ph.D.
Director, London School of Hygiene & Tropical Medicine; Former Executive Director of UNAIDS; GHIT Fund Board Member
- Ann M. Veneman, J.D.
Former Executive Director of UNICEF; Former Secretary of Agriculture; GHIT Fund Board Member
- Mel Spigelman, M.D.
President and CEO, Global Alliance for TB Drug Development (TB Alliance); GHIT Fund Grantee
- Kiyoshi Kurokawa, M.D.
Chair of the Board of GHIT Fund; Academic Fellow, National Graduate Institute for Policy Studies; Chairman, Health and Global Policy Institute
Moderated:
- Ko-Yung Tung, J.D.
Senior Counselor, Morrison & Foerster; GHIT Fund Board Advisor
Where:
Japan Society
333 East 47th Street
New York, NY 10017
###
For more information on this event, please visit http://bit.ly/GHITEvent or
email nseaver@burnesscommunications.com.
About the Global Health Innovative Technology Fund
The Global Health Innovative Technology Fund is a non-profit organization aimed at mobilizing Japanese R&D for global health. A public-private partnership between the Government of Japan, a consortium of Japanese pharmaceutical companies, and the Bill & Melinda Gates Foundation, the GHIT Fund seeks to develop new drugs, vaccines and diagnostics for infectious diseases prevalent in developing countries. More information is available at http://www.ghitfund.org.
[
Share]
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
PUBLIC RELEASE DATE: 30-Oct-2013
[
]
ShareContact: Nick Seaver
nseaver@burnesscommunications.com
301-280-5727
Burness Communications
Engaging new partners to save lives
The Global Health Innovative Technology Fund (GHIT Fund), along with the New York Academy of Sciences and Japan Society, will host a panel discussion comprised of preeminent global health experts to examine recent successes and setbacks in global health and what they see as the secret ingredient to moving a vaccine, cure or diagnostic across the finish line and into the field.
Panelists will provide their unique perspectives on:
- How do these partnerships find success in the face of seemingly insurmountable challenges?
- What have we learned from past successes that make the difference between a breakthrough diagnostic or treatment and a trip back to the drawing board?
- Where are the opportunities for the next big solutions?
- Who is missing from the table in the effort to push back against HIV, TB, malaria and neglected tropical diseases?
- Why should those outside the global health and NGO worlds join this effort?
The discussion will include an opportunity for questions from attendees. A networking reception will follow the panel.
When: 6-8:30pm
November 12, 2013
Who:
Panelists:
- Peter Piot, M.D., Ph.D.
Director, London School of Hygiene & Tropical Medicine; Former Executive Director of UNAIDS; GHIT Fund Board Member
- Ann M. Veneman, J.D.
Former Executive Director of UNICEF; Former Secretary of Agriculture; GHIT Fund Board Member
- Mel Spigelman, M.D.
President and CEO, Global Alliance for TB Drug Development (TB Alliance); GHIT Fund Grantee
- Kiyoshi Kurokawa, M.D.
Chair of the Board of GHIT Fund; Academic Fellow, National Graduate Institute for Policy Studies; Chairman, Health and Global Policy Institute
Moderated:
- Ko-Yung Tung, J.D.
Senior Counselor, Morrison & Foerster; GHIT Fund Board Advisor
Where:
Japan Society
333 East 47th Street
New York, NY 10017
###
For more information on this event, please visit http://bit.ly/GHITEvent or
email nseaver@burnesscommunications.com.
About the Global Health Innovative Technology Fund
The Global Health Innovative Technology Fund is a non-profit organization aimed at mobilizing Japanese R&D for global health. A public-private partnership between the Government of Japan, a consortium of Japanese pharmaceutical companies, and the Bill & Melinda Gates Foundation, the GHIT Fund seeks to develop new drugs, vaccines and diagnostics for infectious diseases prevalent in developing countries. More information is available at http://www.ghitfund.org.
[
Share]
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Source: http://www.eurekalert.org/pub_releases/2013-10/bc-uts103013.php
Related Topics: Jofi Joseph Janet Yellen Capitol shooting Yom Kippur 2013 Kendra Spears
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.